Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,202.00
-85.00 (-3.72%)
Jul 31, 2026, 3:30 PM JST
Astellas Pharma Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Astellas Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,388. The average 1-year stock price forecast is 8.47% higher than the current stock price, while the lowest is ¥1,700 (-22.80%) and the highest is ¥3,000 (+36.24%).
Price Target: ¥2,388 (+8.47%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Astellas Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 9 | 9 | 8 | 8 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains ¥2,950 → ¥3,000 | Buy | Maintains | ¥2,950 → ¥3,000 | +36.24% | Jul 17, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Maintains ¥2,400 → ¥2,300 | Hold | Maintains | ¥2,400 → ¥2,300 | +4.45% | Jul 15, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Sell Maintains ¥1,700 | Sell | Maintains | ¥1,700 | -22.80% | Jul 14, 2026 |
| Bernstein | Bernstein | Hold Maintains ¥2,200 | Hold | Maintains | ¥2,200 | -0.09% | Jul 7, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains ¥2,300 | Hold | Maintains | ¥2,300 | +4.45% | Jun 29, 2026 |
Financial Forecast
Revenue This Year
2.26T
from 2.14T
Increased by 5.62%
Revenue Next Year
2.08T
from 2.26T
Decreased by -7.99%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.